Global Duchenne Muscular Dystrophy Treatment Market 2030 to 2032
Overview
The Global Duchenne Muscular Dystrophy Treatment Market 2030 is expected to reach a 12.21 USD Billion by 2032 and is projected to grow at a CAGR of 18.78% from 2025 to 2032.
Revenue, 2024 (USD Billion)
3.30
Forecast, 2032 (USD Billion)
12.21
CAGR, 2024 - 2032
18.78%
Report Coverage
Global
Global Duchenne Muscular Dystrophy Treatment Market 2030 2018-2032 USD Billion
Global Duchenne Muscular Dystrophy Treatment Market 2030, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 3.30 USD Billion
- Projected Market Size (2032): 12.21 USD Billion
- CAGR (2025-2032): 18.78%
Key Findings of Global Duchenne Muscular Dystrophy Treatment Market 2030
- The Global Duchenne Muscular Dystrophy Treatment Market 2030 was valued at 12.21 USD Billion in 2024.
- The Global Duchenne Muscular Dystrophy Treatment Market 2030 is likely to grow at a CAGR of 18.78% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Parenteral in Route of Administration Segment accounted for the largest share of the market with a revenue of 2.33 USD Billion
- The fastest growing segment Steroid Therapy in Treatment Segment grew Fastest with a CAGR of 19.69% during the forecast period from 2024 to 2032.
Global Duchenne Muscular Dystrophy Treatment Market 2030 Scope
Global Duchenne Muscular Dystrophy Treatment Market 2030 Segmentation & Scope
Therapy
- Dystrophin-Targeted Therapies
- Exon Skipping Approach
- Mutation Suppression
Route of Administration
- Parenteral
- Oral
- Others
End User
- Hospitals
- Specialty Clinics
- Others
- Homecare
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Treatment
- Molecular-Based Therapies
- Steroid Therapy
- Others
Global Duchenne Muscular Dystrophy Treatment Market 2030 Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 3.30 USD Billion |
| Market Value in 2032 | 12.21 USD Billion |
| CAGR (2025-2032) | 18.78% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Therapy,Route of Administration ,End User,Distribution Channel,Treatment |
Regional Insights:
-
Leading Market (2024-2032): Global, leading in terms of revenue 3.30 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 1,537.84 USD Million in 2024.
Segments and Scope
-
Global Duchenne Muscular Dystrophy Treatment Market 2030 to 2032, By Therapy
- Exon Skipping Approach is the largest segment in Global Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a revenue of 1.65 USD Billion in the year 2024.
- Exon Skipping Approach is the Fastest growing segment in Global Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a Growth rate of 19.26 % in forecast period 2025-2032.
-
Global Duchenne Muscular Dystrophy Treatment Market 2030 to 2032, By Route of Administration
- Parenteral is the largest segment in Global Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a revenue of 2.33 USD Billion in the year 2024.
- Parenteral is the Fastest growing segment in Global Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a Growth rate of 19.37 % in forecast period 2025-2032.
-
Global Duchenne Muscular Dystrophy Treatment Market 2030 to 2032, By End User
- Hospitals is the largest segment in Global Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a revenue of 1.63 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in Global Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a Growth rate of 19.37 % in forecast period 2025-2032.
-
Global Duchenne Muscular Dystrophy Treatment Market 2030 to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in Global Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a revenue of 2.01 USD Billion in the year 2024.
- Hospital Pharmacy is the Fastest growing segment in Global Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a Growth rate of 19.33 % in forecast period 2025-2032.
-
Global Duchenne Muscular Dystrophy Treatment Market 2030 to 2032, By Treatment
- Molecular-Based Therapies is the largest segment in Global Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a revenue of 1.70 USD Billion in the year 2024.
- Steroid Therapy is the Fastest growing segment in Global Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a Growth rate of 18.65 % in forecast period 2025-2032.
Global Duchenne Muscular Dystrophy Treatment Market 2030 Company Share Analysis
| Company Name |
|
||
| Pfizer Inc. | |||
| F. Hoffmann-La Roche Ltd. | |||
| PTC Therapeutics. | |||
| Sarepta Therapeutics, Inc. | |||
Global Duchenne Muscular Dystrophy Treatment Market 2030 Geographical Sales Distribution, 2018-2032 USD Billion
Global Duchenne Muscular Dystrophy Treatment Market 2030 Company Profiling
Industry Related Reports
Frequently Asked Questions
The Global Duchenne Muscular Dystrophy Treatment Market 2030 is segmented based on Segmentation Therapy,Route of Administration ,End User,Distribution Channel,Treatment.
Global Duchenne Muscular Dystrophy Treatment Market 2030 was valued at USD 3.30(Revenue in USD Billion) in 2021.
Global Duchenne Muscular Dystrophy Treatment Market 2030 is projected to grow at a CAGR of 18.78% during the forecast period of 2024 to 2032.
The Parenteral segment is expected to dominate the Global Duchenne Muscular Dystrophy Treatment Market 2030, holding a largest market share of 2.33 USD Billion in 2024
Coming Soon....
Global Duchenne Muscular Dystrophy Treatment Market 2030 Scope
Global Duchenne Muscular Dystrophy Treatment Market 2030 Segmentation & Scope
Therapy
- Dystrophin-Targeted Therapies
- Exon Skipping Approach
- Mutation Suppression
Route of Administration
- Parenteral
- Oral
- Others
End User
- Hospitals
- Specialty Clinics
- Others
- Homecare
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Treatment
- Molecular-Based Therapies
- Steroid Therapy
- Others
Frequently Asked Questions
The Global Duchenne Muscular Dystrophy Treatment Market 2030 is segmented based on Segmentation Therapy,Route of Administration ,End User,Distribution Channel,Treatment.
Global Duchenne Muscular Dystrophy Treatment Market 2030 was valued at USD 3.30(Revenue in USD Billion) in 2021.
Global Duchenne Muscular Dystrophy Treatment Market 2030 is projected to grow at a CAGR of 18.78% during the forecast period of 2024 to 2032.
The estimated market value of the Global Duchenne Muscular Dystrophy Treatment Market 2030 for final year is USD 12.21 (USD Billion).
Global Duchenne Muscular Dystrophy Treatment Market 2030 Company Profiling
Frequently Asked Questions
The Global Duchenne Muscular Dystrophy Treatment Market 2030 is segmented based on Segmentation Therapy,Route of Administration ,End User,Distribution Channel,Treatment.
Global Duchenne Muscular Dystrophy Treatment Market 2030 was valued at USD 3.30(Revenue in USD Billion) in 2021.
Global Duchenne Muscular Dystrophy Treatment Market 2030 is projected to grow at a CAGR of 18.78% during the forecast period of 2024 to 2032.
The estimated market value of the Global Duchenne Muscular Dystrophy Treatment Market 2030 for final year is USD 12.21 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.